332 related articles for article (PubMed ID: 19118013)
41. Infrequent occurrence of age-dependent changes in CpG island methylation as detected by restriction landmark genome scanning.
Tra J; Kondo T; Lu Q; Kuick R; Hanash S; Richardson B
Mech Ageing Dev; 2002 Sep; 123(11):1487-503. PubMed ID: 12425956
[TBL] [Abstract][Full Text] [Related]
42. Stable DNMT3L overexpression in SH-SY5Y neurons recreates a facet of the genome-wide Down syndrome DNA methylation signature.
Laufer BI; Gomez JA; Jianu JM; LaSalle JM
Epigenetics Chromatin; 2021 Mar; 14(1):13. PubMed ID: 33750431
[TBL] [Abstract][Full Text] [Related]
43. Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells.
Nguyen C; Liang G; Nguyen TT; Tsao-Wei D; Groshen S; Lübbert M; Zhou JH; Benedict WF; Jones PA
J Natl Cancer Inst; 2001 Oct; 93(19):1465-72. PubMed ID: 11584062
[TBL] [Abstract][Full Text] [Related]
44. High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer.
Rauch TA; Zhong X; Wu X; Wang M; Kernstine KH; Wang Z; Riggs AD; Pfeifer GP
Proc Natl Acad Sci U S A; 2008 Jan; 105(1):252-7. PubMed ID: 18162535
[TBL] [Abstract][Full Text] [Related]
45. Aberrant promoter methylation of the transcription factor genes PAX5 alpha and beta in human cancers.
Palmisano WA; Crume KP; Grimes MJ; Winters SA; Toyota M; Esteller M; Joste N; Baylin SB; Belinsky SA
Cancer Res; 2003 Aug; 63(15):4620-5. PubMed ID: 12907641
[TBL] [Abstract][Full Text] [Related]
46. Transcriptional overlap links DNA hypomethylation with DNA hypermethylation at adjacent promoters in cancer.
Fain JS; Loriot A; Diacofotaki A; Van Tongelen A; De Smet C
Sci Rep; 2021 Aug; 11(1):17346. PubMed ID: 34462486
[TBL] [Abstract][Full Text] [Related]
47. Methylation target array for rapid analysis of CpG island hypermethylation in multiple tissue genomes.
Chen CM; Chen HL; Hsiau TH; Hsiau AH; Shi H; Brock GJ; Wei SH; Caldwell CW; Yan PS; Huang TH
Am J Pathol; 2003 Jul; 163(1):37-45. PubMed ID: 12819009
[TBL] [Abstract][Full Text] [Related]
48. Methylation-mediated silencing of TMS1/ASC is accompanied by histone hypoacetylation and CpG island-localized changes in chromatin architecture.
Stimson KM; Vertino PM
J Biol Chem; 2002 Feb; 277(7):4951-8. PubMed ID: 11733524
[TBL] [Abstract][Full Text] [Related]
49. Oxidative damage targets complexes containing DNA methyltransferases, SIRT1, and polycomb members to promoter CpG Islands.
O'Hagan HM; Wang W; Sen S; Destefano Shields C; Lee SS; Zhang YW; Clements EG; Cai Y; Van Neste L; Easwaran H; Casero RA; Sears CL; Baylin SB
Cancer Cell; 2011 Nov; 20(5):606-19. PubMed ID: 22094255
[TBL] [Abstract][Full Text] [Related]
50. DNA methyltransferase expression and DNA methylation of CPG islands and peri-centromeric satellite regions in human colorectal and stomach cancers.
Kanai Y; Ushijima S; Kondo Y; Nakanishi Y; Hirohashi S
Int J Cancer; 2001 Jan; 91(2):205-12. PubMed ID: 11146446
[TBL] [Abstract][Full Text] [Related]
51. Reversal of GSTP1 CpG island hypermethylation and reactivation of pi-class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide.
Lin X; Asgari K; Putzi MJ; Gage WR; Yu X; Cornblatt BS; Kumar A; Piantadosi S; DeWeese TL; De Marzo AM; Nelson WG
Cancer Res; 2001 Dec; 61(24):8611-6. PubMed ID: 11751372
[TBL] [Abstract][Full Text] [Related]
52. Abnormal CpG island methylation occurs during in vitro differentiation of human embryonic stem cells.
Shen Y; Chow J; Wang Z; Fan G
Hum Mol Genet; 2006 Sep; 15(17):2623-35. PubMed ID: 16870691
[TBL] [Abstract][Full Text] [Related]
53. CpG island hypermethylation profiling of lung cancer using restriction landmark genomic scanning (RLGS) analysis.
Park J; Brena RM; Gruidl M; Zhou J; Huang T; Plass C; Tockman MS
Cancer Biomark; 2005; 1(2-3):193-200. PubMed ID: 17192040
[TBL] [Abstract][Full Text] [Related]
54. Aberrant silencing of the CpG island-containing human O6-methylguanine DNA methyltransferase gene is associated with the loss of nucleosome-like positioning.
Patel SA; Graunke DM; Pieper RO
Mol Cell Biol; 1997 Oct; 17(10):5813-22. PubMed ID: 9315639
[TBL] [Abstract][Full Text] [Related]
55. Hypermethylation of CpG islands is more prevalent than hypomethylation across the entire genome in breast carcinogenesis.
Tan J; Gu Y; Zhang X; You S; Lu X; Chen S; Han X; Sun Y
Clin Exp Med; 2013 Feb; 13(1):1-9. PubMed ID: 22212995
[TBL] [Abstract][Full Text] [Related]
56. DNA hypermethylation accompanied by transcriptional repression in follicular lymphoma.
Bennett LB; Schnabel JL; Kelchen JM; Taylor KH; Guo J; Arthur GL; Papageorgio CN; Shi H; Caldwell CW
Genes Chromosomes Cancer; 2009 Sep; 48(9):828-41. PubMed ID: 19530241
[TBL] [Abstract][Full Text] [Related]
57. Mapping patterns of CpG island methylation in normal and neoplastic cells implicates both upstream and downstream regions in de novo methylation.
Graff JR; Herman JG; Myöhänen S; Baylin SB; Vertino PM
J Biol Chem; 1997 Aug; 272(35):22322-9. PubMed ID: 9268383
[TBL] [Abstract][Full Text] [Related]
58. Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma.
Eads CA; Lord RV; Kurumboor SK; Wickramasinghe K; Skinner ML; Long TI; Peters JH; DeMeester TR; Danenberg KD; Danenberg PV; Laird PW; Skinner KA
Cancer Res; 2000 Sep; 60(18):5021-6. PubMed ID: 11016622
[TBL] [Abstract][Full Text] [Related]
59. The frequency of CpG and non-CpG methylation of Notch3 gene promoter determines its expression levels in breast cancer cells.
Xiao W; Liu X; Niu X; Li C; Guo Y; Tan J; Xiong W; Fan L; Li Y
Exp Cell Res; 2020 Jan; 386(2):111743. PubMed ID: 31770532
[TBL] [Abstract][Full Text] [Related]
60. Dissecting complex epigenetic alterations in breast cancer using CpG island microarrays.
Yan PS; Chen CM; Shi H; Rahmatpanah F; Wei SH; Caldwell CW; Huang TH
Cancer Res; 2001 Dec; 61(23):8375-80. PubMed ID: 11731411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
